已收盘 07-15 16:00:00 美东时间
0.000
0.00%
GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positive non-small cell lung cancer.
07-23 01:39
Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth up to $2.1 billion.
07-08 22:14
https://www.londonstockexchange.com/news-article/GSK/gsk-announces-tender-offer-to-acquire-nuvalent/17655562
06-24 23:16
US stocks down, Dow Jones drops 300 points. Real estate shares up, technology stocks down. U.S. trade deficit shrinks, imports and exports increase.
06-10 00:30
Cantor Fitzgerald analyst Josh Schimmer downgrades Nuvalent (NASDAQ:NUVL) from Overweight to Neutral.
06-09 22:06
Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that it has commenced an
2025-11-18 05:02
Nuvalent shares are trading lower by 6.2% during Tuesday's session. The company priced a $500 million public offering of 5 million shares at $100 each.
2024-09-18 02:37
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite fall...
2024-09-17 00:31
U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on M...
2024-09-16 22:03